Experimental characterization of the pathways by which the carbapenemase KPC-2 evolves high activity against ceftazidime reveals strong epistasis underpinning four major resistance groups, each with distinct phenotypic profiles that may shape the enzyme’s long-term success.
- Laura Dabos
- Inssaf Nedjari
- Alejandro Couce